Feike Jeffrey L., a Tevogen director, received an award of 75,000 shares on 2026-09-11, lifting his resulting holding to 131,435 shares. The award equals about 57.1% of that holding, giving investors a precise measure of the transaction’s size within his post-award ownership.
Key Highlights
- The transaction was recorded on 11 September 2026.
- Feike Jeffrey L. owned 131,435 Tevogen shares after the award.
- The filing identifies the transaction with SEC transaction code A.
Feike Jeffrey L. received 75,000 Tevogen shares, taking his resulting holding to 131,435 shares. The transaction concerns the director’s ownership of Tevogen Inc (NASDAQ: TVGN).
Award Recorded on September 11
The transaction was recorded on 11 September 2026. Feike Jeffrey L. is a director of Tevogen Inc. The filing identifies the transaction with SEC transaction code A. The awarded shares represented about 57.1% of his resulting holding. Transaction code A denotes an award, grant, or other Acquisition from the company.
FAQs
Q: How many Tevogen shares did Feike Jeffrey L. receive?
A: The filing states that Feike Jeffrey L. was awarded 75,000 Tevogen Inc. shares in the transaction. Following the transaction, he owned 131,435 Tevogen Inc. shares.
Q: What was the size of Feike Jeffrey L.’s Tevogen holding after the award?
A: Feike Jeffrey L. held 131,435 Tevogen shares after the transaction. The awarded shares represented about 57.1% of that resulting holding.
Q: What does transaction code A mean for Feike Jeffrey L.’s Tevogen transaction?
A: The filing identifies Feike Jeffrey L.’s transaction with SEC transaction code A. The transaction was recorded on 11 September 2026 for Tevogen director Feike Jeffrey L.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.